Physician profile
Ryan D Forster
NPI 1184854564
$1,119.77
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $159 · 2021: $128 · 2022: $81.77 · 2023: $122 · 2024: $303 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $190.50 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Kaleo, INC. | $116.40 | 2019-2023 | Auvi-Q |
| Cranial Technologies, INC | $112.41 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $109.52 | 2019-2022 | |
| Pfizer INC. | $96.11 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $83.26 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $69.47 | 2024 | Qelbree |
| Sanofi-Aventis U.S. LLC | $67.05 | 2024-2025 | |
| Alk-Abello, INC | $54.90 | 2024-2025 | Grastek, Odactra, Ragwitek |
| Seqirus USA INC | $54.50 | 2024-2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $44.17 | 2025 | Jornay Pm |
| Tris Pharma INC | $34.26 | 2019-2024 | Dyanavel Xr |
| Astrazeneca Pharmaceuticals LP | $32.02 | 2022-2023 | Flumist Quadrivalent |
| Neurelis, INC. | $25.61 | 2022 | |
| Amarin Pharma, INC. | $15.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $14.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Forster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.